Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20210611006Recruiting
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Immunologic response to COVID-19 vaccination. Started May 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20210611006.